News
BrainsWay (Nasdaq:BWAY) today announced the FDA granted expanded clearance for its Deep Transcranial Magnetic Stimulation ...
Zacks Investment Research on MSN
BWAY Shares Gain on FDA Nod for Accelerated Deep TMS Depression Care
BrainsWay Ltd. BWAY recently secured FDA clearance for an accelerated treatment protocol using its Deep Transcranial Magnetic ...
Clinical data shows that BrainsWay’s new accelerated stimulation protocol is comparable to standard Deep TMS in depression ...
MedPage Today on MSN
RFK Jr. Pans Mental Health Care for Kids; Quicker TMS Cleared; COVID, Then Anxiety
BrainsWay announced it received FDA clearance of an accelerated protocol for its deep transcranial magnetic stimulation (TMS) ...
The Horizon® 3.0 Inspire has a compact design allowing for easier portability. The Food and Drug Administration (FDA) has cleared Magstim’s Horizon ® 3.0 Inspire for the treatment of major depressive ...
ALPHARETTA, GEORGIA, USA, March 28, 2023/EINPresswire.com/ -- MagVenture TMS Atlas™ Neuro Navigation System is a time-saving coil positioning system for the ...
In today's fast-paced financial landscape, businesses need more than just traditional banking solutions to manage their cash flow, investments, and payments efficiently. Treasury management systems ...
BrainsWay (NASDAQ:BWAY) shares spiked on Tuesday after the U.S. FDA cleared an additional treatment protocol for the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback